
Chief Complaint
Transplant Diagnosis : Acute myelogenous leukemia ( AML ) ( complex cytogentics refractory to chemotherapy ) . Date of Transplant : 5/6/2010 . Day Post - Transplant : 35 .

Interval History
Diarrhea resolved at this time with soft formed stools , 1-2 per day . Nutrition and fluid intake good . Pt has unchanged mild patches of rash on bilat inner arms and right flank . No pruritis . Pt feels increasingly well with improving strength . .

Pain Management
Pain Scale : 0 ( 0 none ; 10 worst ) . Patient Controlled Analgesics : Not applicable .


Transplant Status
PROTOCOL / TREATMENT PLAN : 739 / 1932 .
TRANSPLANT TYPE allogeneic unrelated , matched peripheral blood stem cell transplant .
CMV SEROLOGY Donor negative , Recipient negative .
PREPARATIVE REGIMEN : Myeloablative TBI , cyclophosphamide .
GVHD Prophylaxis Methotrexate , Tacrolimus .

Allergies

NKA



Medications

Scheduled Medications
acyclovir 800 mg PO BID
budesonide 3 mg PO TID ( budesonide 3 mg oral capsule , extended release )
diphenhydrAMINE 25-5 0 mg PO Q4 Hours
emollients , topical apply to sun exposed areas when outdoors Topical ( sunscreen SPF - 30-50 lotion )
fluconazole 400 mg PO QDay
heparin flush 3 ml for flush IV
magnesium oxide See Instructions : ( 400 mg once daily x 3 days , 400 mg BID x 3 days , 400 mg TID x 3 days )
magnesium sulfate 40 mEq IV BID
multivitamin no iron 2 tab Chew QDay
pantoprazole 40 mg PO QDay
sodium chloride 10 ml for flush IV ( Normal Saline Flush )
sulfamethoxazole-trimethoprim 1 tab PO BID on QMTu ( Bactrim DS )
tacrolimus 1.5 mg PO Q12 Hours
ursodiol 600 mg PO BID

PRN Medications
lorazepam 0.5 - 2mg PO Q4 Hours PRN ( for nausea / vomiting )
nepafenac ophthalmic 1 drop ( s ) Left EYE TID PRN ( - ) ( Nevanac )




Review of Systems
CONSTITUTIONAL Symptoms
Denies fever . Denies chills . Denies weakness . Denies sweats .
ENMT
Denies rhinorrhea . Denies oral lesions . Denies sinus congestion . Denies sore throat .
CARDIOVASCULAR Symptoms
Denies chest pain . Denies lightheadedness . Denies swelling .
RESPIRATORY Symptoms
Denies cough . Denies shortness of breath .
GASTROINTESTINAL Symptoms denies abdominal pain , denies nausea , denies vomiting , denies diarrhea , denies constipation .
MUSCULOSKELETAL Symptoms denies muscle pain .
SKIN Symptoms rash , denies itching .
NEUROLOGIC Symptoms denies headaches , denies dizziness .
HEME / LYMPH Symptoms denies bleeding , denies bruising .


Physical Examination
Vital Signs Vital Signs Data .
06/10/2010 09:15 Temperature - C 36.1 degC
Heart Rate 91 bpm
Respiratory Rate 16 br / min
SBP - Noninvasive 108 mmHg
DBP - Noninvasive 85 mmHg
BP Method Automatic
BP Extremity LEFT , Arm , Upper
Weight : Height / Weight / BMI - General .
06/10/2010 09:15 DAILY Weight - kg 81.20 kg CONSTITUTIONAL : well-appearing , no apparent distress .
MENTAL STATUS : alert and oriented x3 , Level of Consciousness : alert , normal mood / affect .
EYES : pupils equal , round , reactive to light , extraocular movements intact , EOMI , normal sclera .
EARS , NOSE , MOUTH , and THROAT : normal mouth and dentition , normal oropharynx .
RESPIRATORY / CHEST : normal respiratory effort , lung sounds clear to auscultation bilaterally . .
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop , no cyanosis or edema .
GASTROINTESTINAL : normal bowel sounds , abdomen non-tender , abdomen non-distended , no hepatomegaly , no splenomegaly .
MUSCULOSKELETAL : normal gait / stance .
SKIN : Lesions / Rash : BSA 6 % , rash , erythema ( mild maculopapular rash at base of throat and patches bilat inner arms and right flank . Also fine scattered erythematous papular rash on forearms . ) , hickman line intact . Small area of blister and erythema next to line exit . Non - tender . .
NEUROLOGIC : cranial nerves II - XII intact .


Laboratory Studies

Laboratory Studies ( Most recent results in 24 hour range . )

RESULTS FROM TODAY
RESULTS FROM YESTERDAY

06/10/10 08:01
- - -


| - ICa - - -
| - ICa - - -
139
106
23
| - Ca 10.2

- - -
- - -
- - -
| - Ca - - -
- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 139
| - Mg 1.6

- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < - - -
| - Mg - - -
4.5
23
0.8
| - Phos 4.6

- - -
- - -
- - -
| - Phos - - -


RESULTS FROM TODAY
RESULTS FROM YESTERDAY

06/10/10 08:01
06/09/10 13:57


12.6
| - PT - - -
12.5
| - PT - - -
11.30 ] - - - - - - - - - - - - - - - - - - - - - - [ 118
| - INR - - -
13.26 ] - - - - - - - - - - - - - - - - - - - - - - [ 127
| - INR - - -

38
| - PTT - - -
37
| - PTT - - -


( Most recent results for 24 hour range . )
Individual Labs
06/10/2010 08:01
LD ( Total )
161
06/10/2010 08:01
AST ( GOT )
16
06/10/2010 08:01
ALT ( GPT )
19
06/10/2010 08:01
Bilirubin ( Total )
0.5
06/10/2010 08:01
Bilirubin ( Direct )
0.1
06/10/2010 08:01
Protein ( Total )
6.8
06/10/2010 08:01
Albumin
3.6
06/10/2010 08:01
MCV
93
06/10/2010 08:01
Neutrophils
6.66

Antibiotics
No Results Found .

( Most Recent Results for Prior 7 Days . )
Immunosuppressant
06/10/2010 05:00
Tacrolimus Level by LCMSMS
Pending

( Most Recent Results for Prior 14 Days . )
CMV Results
05/31/2010 09:50
CMV Quant ( PCR ) Result
None detected .


Viral / CMV Monitoring
Viral Culture And Antigen Detection .
06/07/2010 08:42 CMV Antigenemia Result CMV Antigenemia Result
CMV Positive Cells / Slide 0.0
CMV Antigenemia sent to Viro Specimen received by UW Virology Lab at Children 's Hospital .


Procedures / Diagnostic Studies
PATHOLOGY :
BMA 6/3/10 :
Pathology : Normocellular bone marrow , day 28 post-transplant , with morphological remission but 1-2 % of white cells having
phenotypic characteristics of minimal residual disease .

Flow Cytometry : A very small population of abnormal myeloid blasts is identified with an immunophenotype similar to that seen previously ( see HP1 0-05930 ) . These blasts comprise approximately 0.006 % of total white cells , and express CD33 ( decreased ) , CD34 ( increased ) , CD117 ( absent ) and HLA-DR ( decreased to absent ) with normal expression of CD13 , CD38 , CD45 and CD71 without CD5 , CD7 , CD15 , CD19 , CD56 , or CD64 . This finding is compatible with minimal persistent disease involvement by the patientï¿½s acute myeloid leukemia .

Cyto : Normal 46XY . .


Assessment / Plan
PRIMARY DISEASE : 45 year old man with refractory AML with complex cytogenetics , now day 35 s/p MURD PBSCT with TBI / Cy conditioning , BMA on 6 / 3 with persisting disease by flow of 0.006 % abnormal blasts . Cyto and path normal . Peripheral flow negative . .
HEMATOLOGIC : platelet threshold : 10 thousand , Hematocrit threshold : 26 % , Engrafted . Transfusion independent .
Leukocytosis , improved : BMA 6/3/10 as above showing persistent AML . CBC differential today shows slightly improved monocytes , metamyelocytes , and myelocytes . We will monitor CBCs and repeat peripheral blood flow in 1-2 weeks . BMA in 2-3 weeks time . .
INFECTIOUS DISEASE :
Infection Prophylaxis : Antifungal agent ( s ) : Fluconazole , Bactrim for PCP prophy , Antiviral agent ( s ) : Acyclovir .
Plan :
Afebrile . No infections . .
DRUG MONITORING : Tacrolimus : level pending , Tacrolimus goal 5-15 .
GRAFT-VERSUS-HOST DISEASE :
History of GVHD : GI tract .
Active SKIN GVHD Assessment : Differential Diagnosis : GVHD , Drug reaction , contact dermatitis .
Plan :
FK - 506 and post transplant methotrexate prophylaxis .

New onset diarrhea on 5 / 19 , EGD / Flex Sig 5 / 20 . Started empiric beclothemasone and budesonide on 5 / 20 per GI recommendations . Most likely conditioning toxicity , c.diff , and antibiotic effect with diarrhea now resolved . Final pathology suggestive of residual chemotherapy toxicity versus early GVHD . B & B now discontinued .

Skin rashes with mild suspicion for GVHD . Will follow for changes and obtain biopsy if worsening . .
REGIMEN RELATED TOXICITY : Fatigue , weakness : Improved today . Continue to follow . .
GASTROINTESTINAL : Diarrhea , resolved . .
FLUIDS , ELECTROLYTES & NUTRITION : Hypomagnesemia , requiring daily IV repletion . Appetite and food intake signficantly improved . Fluid intake adquate , no IV fluids necessary . Mag level 1.6 today . Continue IV repletion 40 meq BID and slowly start Mag oxide PO . .
Derm : Central line dressing changed to biopatch due to blistering . Culture sent . .

Comments
Plan : Follow CBCs , repeat PB flow in 1-2 weeks .


Signature

Judson Hall , PA-C
FHCRC / SCCA
Pager 314-0063

